Search > Results

You searched for: EV250037 (EV-TRACK ID)

Showing 1 - 2 of 2

Experiment number
  • If needed, multiple experiments were identified in a single publication based on differing sample types, separation protocols and/or vesicle types of interest.
Species
  • Species of origin of the EVs.
Separation protocol
  • Gives a short, non-chronological overview of the different steps of the separation protocol.
    • (d)(U)C = (differential) (ultra)centrifugation
    • DG = density gradient
    • UF = ultrafiltration
    • SEC = size-exclusion chromatography
    • IAF = immuno-affinity capture
Details EV-TRACK ID Experiment nr. Species Sample type Separation protocol First author Year EV-METRIC
EV250037 1/2 Mus musculus Tissue (d)(U)C
DG
Filtration
Hurwitz SN 2019 67%

Study summary

Full title
All authors
Hurwitz SN, Olcese JM, Meckes DG
Journal
J Vis Exp
Abstract
Circulating and interstitial small membrane-bound extracellular vesicles (EVs) represent promising t (show more...)Circulating and interstitial small membrane-bound extracellular vesicles (EVs) represent promising targets for the development of novel diagnostic or prognostic biomarker assays, and likely serve as important players in the progression of a vast spectrum of diseases. Current research is focused on the characterization of vesicles secreted from multiple cell and tissue types in order to better understand the role of EVs in the pathogenesis of conditions including neurodegeneration, inflammation, and cancer. However, globally consistent and reproducible techniques to isolate and purify vesicles remain in progress. Moreover, methods for extraction of EVs from solid tissue ex vivo are scarcely described. Here, we provide a detailed protocol for extracting small EVs of interest from whole fresh or frozen tissues, including brain and tumor specimens, for further characterization. We demonstrate the adaptability of this method for multiple downstream analyses, including electron microscopy and immunophenotypic characterization of vesicles, as well as quantitative mass spectrometry of EV proteins. (hide)
EV-METRIC
67% (79th percentile of all experiments on the same sample type)
 Reported
 Not reported
 Not applicable
EV-enriched proteins
Protein analysis: analysis of three or more EV-enriched proteins
non EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody specifics
Protein analysis: antibody clone/reference number and dilution
lysate preparation
Protein analysis: lysis buffer composition
Study data
Sample type
Tissue
Sample origin
Brain
Focus vesicles
EVs
Separation protocol
Separation protocol
  • Gives a short, non-chronological overview of the
    different steps of the separation protocol.
    • dUC = (Differential) (ultra)centrifugation
    • DG = density gradient
    • UF = ultrafiltration
    • SEC = size-exclusion chromatography
    • IAF = immuno-affinity capture
(Differential) (ultra)centrifugation
Density gradient
Filtration
Adj. k-factor
8.86 (washing)
Protein markers
EV: CD81/ Flotillin_2/ HSP70/ TSG101/ syntenin1/ Alix
non-EV: None
Proteomics
yes
EV density (g/ml)
1.068-1.101
Show all info
Study aim
Technical analysis comparing/optimizing EV-related methods
Sample
Species
Mus musculus
Sample Type
Tissue
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Below or equal to 800 g
Between 800 g and 10,000 g
Between 10,000 g and 50,000 g
Between 100,000 g and 150,000 g
Pelleting performed
Yes
Pelleting: rotor type
MLS-50
Pelleting: speed (g)
100000
Wash: volume per pellet (ml)
11
Wash: time (min)
120
Wash: Rotor Type
MLS-50
Wash: speed (g)
100000
Wash: adjusted k-factor
8.862
Density gradient
Type
Discontinuous
Number of initial discontinuous layers
3
Lowest density fraction
10
Highest density fraction
30
Total gradient volume, incl. sample (mL)
6
Sample volume (mL)
1.5
Orientation
Bottom-up
Speed (g)
268000
Duration (min)
50
Fraction volume (mL)
0.49
Fraction processing
Centrifugation
Pelleting: volume per fraction
11
Pelleting: speed (g)
100000
Pelleting: adjusted k-factor
1.009
Filtration steps
0.45µm > x > 0.22µm,
EV-subtype
Distinction between multiple subtypes
Density
Used subtypes
low density 1.057 g/ml
Characterization: Protein analysis
Protein Concentration Method
Fluorometric assay
Western Blot
Detected EV-associated proteins
Alix/ TSG101
Proteomics database
No
Characterization: Lipid analysis
No
Characterization: Particle analysis
NTA
Report type
Size range/distribution
Reported size (nm)
75-455
EM
Image type
Close-up, Wide-field
EV250037 2/2 Mus musculus Tissue (d)(U)C
DG
Filtration
Hurwitz SN 2019 55%

Study summary

Full title
All authors
Hurwitz SN, Olcese JM, Meckes DG
Journal
J Vis Exp
Abstract
Circulating and interstitial small membrane-bound extracellular vesicles (EVs) represent promising t (show more...)Circulating and interstitial small membrane-bound extracellular vesicles (EVs) represent promising targets for the development of novel diagnostic or prognostic biomarker assays, and likely serve as important players in the progression of a vast spectrum of diseases. Current research is focused on the characterization of vesicles secreted from multiple cell and tissue types in order to better understand the role of EVs in the pathogenesis of conditions including neurodegeneration, inflammation, and cancer. However, globally consistent and reproducible techniques to isolate and purify vesicles remain in progress. Moreover, methods for extraction of EVs from solid tissue ex vivo are scarcely described. Here, we provide a detailed protocol for extracting small EVs of interest from whole fresh or frozen tissues, including brain and tumor specimens, for further characterization. We demonstrate the adaptability of this method for multiple downstream analyses, including electron microscopy and immunophenotypic characterization of vesicles, as well as quantitative mass spectrometry of EV proteins. (hide)
EV-METRIC
55% (14th percentile of all experiments on the same sample type)
 Reported
 Not reported
 Not applicable
EV-enriched proteins
Protein analysis: analysis of three or more EV-enriched proteins
non EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody specifics
Protein analysis: antibody clone/reference number and dilution
lysate preparation
Protein analysis: lysis buffer composition
Study data
Sample type
Tissue
Sample origin
Lung tumor
Focus vesicles
EVs
Separation protocol
Separation protocol
  • Gives a short, non-chronological overview of the
    different steps of the separation protocol.
    • dUC = (Differential) (ultra)centrifugation
    • DG = density gradient
    • UF = ultrafiltration
    • SEC = size-exclusion chromatography
    • IAF = immuno-affinity capture
(Differential) (ultra)centrifugation
Density gradient
Filtration
Adj. k-factor
8.86 (washing)
Protein markers
EV: None
non-EV: None
Proteomics
no
EV density (g/ml)
1.117-1.157
Show all info
Study aim
Technical analysis comparing/optimizing EV-related methods
Sample
Species
Mus musculus
Sample Type
Tissue
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Below or equal to 800 g
Between 800 g and 10,000 g
Between 10,000 g and 50,000 g
Between 100,000 g and 150,000 g
Pelleting performed
Yes
Pelleting: rotor type
MLS-50
Pelleting: speed (g)
100000
Wash: volume per pellet (ml)
11
Wash: time (min)
120
Wash: Rotor Type
MLS-50
Wash: speed (g)
100000
Wash: adjusted k-factor
8.862
Density gradient
Type
Discontinuous
Number of initial discontinuous layers
3
Lowest density fraction
10
Highest density fraction
30
Total gradient volume, incl. sample (mL)
6
Sample volume (mL)
1.5
Orientation
Bottom-up
Speed (g)
268000
Duration (min)
50
Fraction volume (mL)
0.49
Fraction processing
Centrifugation
Pelleting: volume per fraction
11
Pelleting: speed (g)
100000
Pelleting: adjusted k-factor
1.009
Filtration steps
0.45µm > x > 0.22µm,
EV-subtype
Distinction between multiple subtypes
Density
Used subtypes
high density 1.144 g/ml
Characterization: Protein analysis
Protein Concentration Method
Fluorometric assay
Western Blot
Detected EV-associated proteins
Alix/ Flotillin-2/ HSC70/ TSG101/ syntenin1
Not detected EV-associated proteins
CD81
Characterization: Lipid analysis
No
Characterization: Particle analysis
None
1 - 2 of 2
  • CM = Commercial method
  • dUC = differential ultracentrifugation
  • DG = density gradient
  • UF = ultrafiltration
  • SEC = size-exclusion chromatography
EV-TRACK ID
EV250037
species
Mus musculus
sample type
Tissue
condition
Brain
Lung tumor
separation protocol
dUC/
Density gradient/ Filtration
dUC/
Density gradient/ Filtration
EV subtype
low
density 1.057 g/ml
high
density 1.144 g/ml
Exp. nr.
1
2
EV-METRIC %
67
55